Chlorzoxazone | Interleukin Related interleukin-related.com

Product Name :
Chlorzoxazone

Search keywords :
Chlorzoxazone

drugId :
null

Target Vo:
Unidentified

Target Vo Short Name :
Unidentified

Moa_Name:
Undisclosed

First Approval Country :
Canada

First Approval Date Filter:
null

Origin Company_Name :

Active Company_Name :
Jiangsu Shenlong Pharmaceutical Co Ltd

Active Indication_Name:
Muscle Spasticity

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Tarextumab site
xCT Rabbit mAb manufacturer
DNMT1 Antibody (YA781): DNMT1 Antibody (YA781) is a non-conjugated and Mouse origined monoclonal antibody about 183 kDa, targeting to DNMT1. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts